نتایج جستجو برای: پروبیوتیک abt 10

تعداد نتایج: 1019339  

Journal: :Cancer research 2008
Shengbing Huang Frank A Sinicrope

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been shown to induce mitochondrial apoptotic signaling that can be negatively regulated by prosurvival Bcl-2 proteins. ABT-737 is a small-molecule BH3 mimetic that binds to and antagonizes Bcl-2/Bcl-x(L) but not Mcl-1. We show that ABT-737 can synergistically enhance TRAIL-mediated cytotoxicity in human pancreatic cancer cell l...

2009
Angela M. Keuling Kathleen E. A. Felton Arabesque A. M. Parker Majid Akbari Susan E. Andrew Victor A. Tron

BACKGROUND Malignant melanoma is resistant to almost all conventional forms of chemotherapy. Recent evidence suggests that anti-apoptotic proteins of the Bcl-2 family are overexpressed in melanoma and may contribute to melanoma's striking resistance to apoptosis. ABT-737, a small-molecule inhibitor of Bcl-2, Bcl-xl and Bcl-w, has demonstrated efficacy in several forms of leukemia, lymphoma as w...

Journal: :Autonomic neuroscience : basic & clinical 2001
H Bettermann D Cysarz A Portsteffen H C Kümmell

This single-blind placebo-controlled study was designed to investigate the dose-dependent vagolytic and vagotonic effects after a single oral administration of Atropa belladonna tincture (ABT, 0.1 mg/ml alkaloid concentration, atropine/scopolamine = 20:1). In eight healthy young subjects, heart rate and noninvasive arterial finger blood pressure were recorded simultaneously over 4 h after oral ...

2014
Nicole L. Yohn Jill R. Turner Julie A. Blendy Kumiko Taguchi Kimimasa Sakata Wakana Ohashi Takahiro Imaizumi Joji Imura Yuichi Hattori Hyun Kim Jae Suk Woo Yong Keun Kim Hyung Kim Robin L. Thurmond Bin Chen Paul J. Dunford Andrew J. Greenspan Evgeniy Panzhinskiy Yinan Hua Paul A. Lapchak Elena Topchiy Teresa E. Lehmann Jun Ren Takato Hiranita Derek S. Wilkinson Weimin C. Hong Mu-Fa Zou Theresa A. Kopajtic Paul L. Soto Carl R. Lupica Amy H. Newman Neil E. Rowland Kimberly L. Robertson Rajeev Sakhuja Raymond G. Booth Wei Li Benjamin C. Yaden Johnny E. Croy Yan Wang Jonathan M. Wilson Amita Datta-Mannan Pamela Shetler Andrea Milner Henry U. Bryant Jessica Andrews Guoli Dai Venkatesh Krishnan Miki Aihara Hiroyuki Fujiki Hiroshi Mizuguchi Katsuji Hattori Koji Ohmoto Makoto Ishikawa Keisuke Nagano Yoshitaka Yamamura Catherine B. Beidler Ramona J. Petrovan Elaine M. Conner Jeffrey S. Boyles Derek D. Yang Shannon M. Harlan Shaoyou Chu Bernice Ellis Robert L. Johnson Anja Stauber Derrick R. Witcher Matthew D. Breyer Josef G. Heuer Bernhard Ryffel

Although nicotine mediates its effects through several nicotinic acetylcholine receptor (nAChR) subtypes, it remains to be determined which nAChR subtypes directly mediate heightened anxiety during withdrawal. Relative success in abstinence has been found with the nAChR partial agonist varenicline (Chantix; Pfizer, Groton, CT ); however, treatment with this drug fails to alleviate anxiety in in...

پایان نامه :وزارت علوم، تحقیقات و فناوری - دانشگاه علوم کشاورزی و منابع طبیعی گرگان - دانشکده علوم کشاورزی 1393

این مطالعه به منظور امکان تولید پروبیوتیک محرک رشد به روش تخمیر میکروبی و تاثیر آن بر عملکرد، جمعیت میکروبی دستگاه گوارش، خصوصیات پرزهای روده و بیان ژن این مطالعه به منظور امکان تولید پروبیوتیک محرک رشد به روش تخمیر میکروبی و تاثیر آن بر عملکرد، جمعیت میکروبی دستگاه گوارش، خصوصیات پرزهای روده و بیان ژن کبدی igf-i در جوجه‏های گوشتی انجام شد. چهار تیمار آزمایشی بر پایه ضایعات کشتارگاه طیور، سطوح ...

2011
Harsh Vardhan Jain Michael Meyer-Hermann

5 Resistance to standard chemotherapy (carboplatin þ paclitaxel) is one of the leading causes of therapeutic 6 failure in ovarian carcinomas. Emergence of chemoresistance has been shown to be mediated in part by 7 members of the Bcl family of proteins including the antiapoptotic protein Bcl-xL, whose expression is correlated 8 with shorter disease-free intervals in recurrent disease. ABT-737 is...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2016
Xiaojia Niu Jianyun Zhao Jun Ma Chengzhi Xie Holly Edwards Guan Wang J Timothy Caldwell Shengyan Xiang Xiaohong Zhang Roland Chu Zhihong J Wang Hai Lin Jeffrey W Taub Yubin Ge

PURPOSE To investigate the molecular mechanism underlying intrinsic resistance to ABT-199. EXPERIMENTAL DESIGN Western blots and real-time RT-PCR were used to determine levels of Mcl-1 after ABT-199 treatment alone or in combination with cytarabine or daunorubicin. Immunoprecipitation of Bim and Mcl-1 were used to determine the effect of ABT-199 treatment on their interactions with Bcl-2 fami...

Journal: :Oncology reports 2014
Xiaohui Wang Zhimin Gu Gongquan Li Shufeng Zhang Zhenjie Cao Zhanfeng Yang Guangzhi Liu

Neuroblastoma is an aggressive childhood disease. Even with intensive conventional treatments, the long term survival rate for children with neuroblastoma remains less than 40%, highlighting the importance of finding new therapies. Bcl-2 family proteins play crucial roles in survival, proliferation and chemotherapeutic resistance of neuroblastoma cells. Therefore, targeting Bcl-2 with small mol...

Journal: :Blood 2011
Sayer Al-Harbi Brian T Hill Suparna Mazumder Kamini Singh Jennifer Devecchio Gaurav Choudhary Lisa A Rybicki Matt Kalaycio Jaroslaw P Maciejewski Janet A Houghton Alexandru Almasan

The antiapoptotic BCL-2 proteins regulate lymphocyte survival and are over-expressed in lymphoid malignancies, including chronic lymphocytic leukemia. The small molecule inhibitor ABT-737 binds with high affinity to BCL-2, BCL-XL, and BCL-W but with low affinity to MCL-1, BFL-1, and BCL-B. The active analog of ABT-737, navitoclax, has shown a high therapeutic index in lymphoid malignancies; dev...

Journal: :Archives of neurology 2001
O Rascol J G Nutt O Blin C G Goetz J M Trugman C Soubrouillard J H Carter L J Currie N Fabre C Thalamas W W Giardina S Wright

BACKGROUND Dyskinesias are a frequent adverse effect of long-term levodopa therapy. The relative contribution of dopamine D(1) and D(2) receptor function to the pathophysiology of levodopa-induced dyskinesias remains a matter of controversy. OBJECTIVE To establish whether a selective D(1) dopamine agonist induces more or less dyskinesia than levodopa in primed dyskinetic patients with Parkins...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید